Showing results (71-80 of 17,194) with videos related to
Sort By:
Pageof 1,720
Gynecologic Oncology|September 1, 1994
A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancerS Kirmani, P S Braly, E F McClay, et al.American Journal of Clinical Oncology|February 1, 1995
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinomaE F McClay, P D Braly, S Kirmani, et al.Journal of Peptide Science : an Official Publication of the European Peptide Society|February 16, 2000
Synthesis, conformational analysis and bioactivity of Lan-7, a lanthionine analog of TT-232H Li, X Jiang, S B Howell, et al.Annals of Internal Medicine|July 1, 1984
Intraperitoneal chemotherapy with melphalanS B Howell, C E Pfeifle, R A OlshenCancer|January 15, 1983
Effect of allopurinol on the toxicity of high-dose 5-fluorouracil administered by intermittent bolus injectionS B Howell, C E Pfeifle, W E WungAnalytical Biochemistry|November 15, 1984
A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrateP A Andrews, W E Wung, S B HowellBritish Journal of Cancer|January 19, 2000
Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cellsS Isonishi, K Ohkawa, T Tanaka, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Pharmacokinetics and toxicity of 5-day continuous infusion of vinblastineJ A Young, S B Howell, M R GreenMolecular Pharmacology|December 1, 1986
Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletionP A Andrews, M P Murphy, S B HowellSeminars in Oncology|June 1, 1992
Enhancement of the loss of multiple drug resistance by hydroxyureaR D Christen, D R Shalinsky, S B HowellPageof 1,720